ACM
DICE

Asymmetry Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Asymmetry Capital Management’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$4.69M Sell
185,201
-89,964
-33% -$2.64M 2.49% 19
2021
Q3 		$9.01M Buy
+275,165
New +$9.37M 5.42% 6

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Asymmetry Capital Management's DICE Position: Q4 2021 in Review

Asymmetry Capital Management reduced its DICE Therapeutics, Inc. Common Stock (DICE) stake by 33% in Q4 2021, selling an estimated $2.64M and leaving 185,201 shares worth $4.69M. The position accounts for 2.49% of the portfolio, ranked #19.

Asymmetry Capital Management first reported a position in DICE in Q3 2021 and has held it in 2 quarters since. The position peaked at $9.01M in Q3 2021. 69 funds tracked by Wall St. Rank hold DICE as of Q4 2021.

  • Asymmetry Capital Management held 185,201 shares of DICE Therapeutics, Inc. Common Stock worth $4.69M as of Q4 2021.
  • Asymmetry Capital Management sold 89,964 DICE Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $2.64M.
  • DICE Therapeutics, Inc. Common Stock made up 2.49% of Asymmetry Capital Management's portfolio in Q4 2021, its #19 holding.
  • Asymmetry Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and has held it in 2 quarters since.
  • Asymmetry Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $9.01M in Q3 2021.
  • 69 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.